Evidence map›Paper›PMID 30579771›Full record

ReviewPatient education and counseling2019

Communicating uncertainty in cancer prognosis: A review of web-based prognostic tools.

Mark Harrison, Paul K J Han, Borsika Rabin, Madelaine Bell, Hannah Kay, Luke Spooner, Stuart Peacock, Nick Bansback

Abstract readReview
In one paragraph

Review in Patient education and counseling, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Uncertainties in the NICU: a scoping review to inform a tailored taxonomy.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  6. Article
  7. Article
  8. The impact of a web-based prognostic calculator on prognostic confidence in outpatient palliative care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mark HarrisonFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada; Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada. Electronic address: mark.harrison@ubc.ca.
Paul K J HanCenter for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, 04101, USA. Electronic address: hanp@mmc.org.
Borsika RabinDepartment of Family Medicine and Public Health, School of Medicine University of California San Diego, La Jolla, CA, 92093, USA; Department of Family Medicine and Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), School of Medicine, University of Colorado, Aurora, CO, 80045, USA. Electronic address: barabin@ucsd.edu.
Madelaine BellFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. Electronic address: m.z.bell@ubc.ca.
Hannah KayCenter for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, 04101, USA. Electronic address: hannah.kay@utexas.edu.
Luke SpoonerFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. Electronic address: luke.spooner@ubc.ca.
Stuart PeacockCanadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency, Vancouver, BC, V5Z 1L3, Canada; Leslie Diamond Chair in Cancer Survivorship, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada. Electronic address: speacock@bccrc.ca.
Nick BansbackCentre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. Electronic address: nick.bansback@ubc.ca.

Funding

Canadian Institutes for Health ResearchIntramural NIH HHS Z99 HG999999NCI NIH HHS HHSN261201000010CNCI NIH HHS HHSN261201200001INCI NIH HHS HHSN261201200010I
6 · The paper itself

Abstract

Objective To review how web-based prognosis tools for cancer patients and clinicians describe aleatory (risk estimates) and epistemic (imprecision in risk estimates) uncertainties. Methods We reviewed prognostic tools available online and extracted all uncertainty descriptions. We adapted an existing classification and classified each extracted statement by presentation of uncertainty. Results We reviewed 222 different prognostic risk tools, which produced 772 individual estimates. When describing aleatory uncertainty, almost all (90%) prognostic tools included a quantitative description, such as "chances of survival after surgery are 10%", though there was heterogeneity in the use of percentages, natural frequencies, and use of graphics. Only 14% of tools described epistemic uncertainty. Of those that did, most used a qualitative prefix such as "about" or "up to", while 22 tools described quantitative descriptions using confidence intervals or ranges. Conclusions Considerable heterogeneity exists in the way uncertainties are communicated in cancer prognostic tools. Few tools describe epistemic uncertainty. This variation is predominately explained by a lack of evidence and consensus in risk communication, particularly for epistemic uncertainty. Practice Implications As precision medicine seeks to improve prognostic estimates, the community may not be equipped with the tools to communicate the results accurately and effectively to clinicians and patients.

Indexed as

CommunicationInternetUncertaintyAdultFemaleHumansMaleNeoplasmsPatient Education as TopicPerceptionPrognosisRisk AssessmentCommunicationPrognosisSurvivalUncertainty

Identifiers

PMID30579771
PMCPMC6491222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.